Vanguard Group Inc Tempest Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
34Shares Held
1.43MCall Options Held
161KPut Options Held
78K-
Black Rock Inc. New York, NY508KShares$1.13 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$294,5450.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$288,9610.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$235,4880.05% of portfolio
-
Bank Of America Corp Charlotte, NC43KShares$95,9540.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $23.2M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...